CN103995106B - For the test strips and preparation method thereof of specificity perfumery anaphylactogen IgE examination - Google Patents
For the test strips and preparation method thereof of specificity perfumery anaphylactogen IgE examination Download PDFInfo
- Publication number
- CN103995106B CN103995106B CN201410232549.3A CN201410232549A CN103995106B CN 103995106 B CN103995106 B CN 103995106B CN 201410232549 A CN201410232549 A CN 201410232549A CN 103995106 B CN103995106 B CN 103995106B
- Authority
- CN
- China
- Prior art keywords
- green onion
- solution
- antigen
- test strips
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims description 25
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000000427 antigen Substances 0.000 claims abstract description 36
- 102000036639 antigens Human genes 0.000 claims abstract description 36
- 108091007433 antigens Proteins 0.000 claims abstract description 36
- 239000010931 gold Substances 0.000 claims abstract description 24
- 229910052737 gold Inorganic materials 0.000 claims abstract description 24
- 239000000084 colloidal system Substances 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 7
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 7
- 229920002301 cellulose acetate Polymers 0.000 claims abstract description 4
- 239000012528 membrane Substances 0.000 claims abstract description 4
- 241000234282 Allium Species 0.000 claims description 34
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 34
- 230000000890 antigenic effect Effects 0.000 claims description 21
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- 239000003381 stabilizer Substances 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 10
- 229920000151 polyglycol Polymers 0.000 claims description 10
- 239000010695 polyglycol Substances 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 238000005238 degreasing Methods 0.000 claims description 6
- 238000004458 analytical method Methods 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 230000000172 allergic effect Effects 0.000 abstract description 6
- 208000010668 atopic eczema Diseases 0.000 abstract description 6
- 239000000243 solution Substances 0.000 description 39
- 238000003745 diagnosis Methods 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 10
- 239000013566 allergen Substances 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 235000009754 Vitis X bourquina Nutrition 0.000 description 5
- 235000012333 Vitis X labruscana Nutrition 0.000 description 5
- 240000006365 Vitis vinifera Species 0.000 description 5
- 235000014787 Vitis vinifera Nutrition 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000003556 assay Methods 0.000 description 4
- 239000003547 immunosorbent Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 240000004784 Cymbopogon citratus Species 0.000 description 3
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 241000532370 Atla Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 241000233855 Orchidaceae Species 0.000 description 2
- OEYQBKYISMRWQB-UHFFFAOYSA-N Santal Chemical compound C=1C(OC)=CC(O)=C(C2=O)C=1OC=C2C1=CC=C(O)C(O)=C1 OEYQBKYISMRWQB-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 208000018631 connective tissue disease Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000005558 fluorometry Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010015251 Erythroblastosis foetalis Diseases 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 208000027530 Meniere disease Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 235000019083 Osmanthus fragrans Nutrition 0.000 description 1
- 244000242564 Osmanthus fragrans Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010042742 Sympathetic ophthalmia Diseases 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 244000089698 Zanthoxylum simulans Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 208000002205 allergic conjunctivitis Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 230000002460 anti-migrenic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000024998 atopic conjunctivitis Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 208000001031 fetal erythroblastosis Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- DKJCUVXSBOMWAV-PCWWUVHHSA-N naltrindole Chemical compound N1([C@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CC2=C3[CH]C=CC=C3N=C25)O)CC1)O)CC1CC1 DKJCUVXSBOMWAV-PCWWUVHHSA-N 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000007084 physiological dysfunction Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 206010040400 serum sickness Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The invention provides a kind of test strips for specificity perfumery anaphylactogen IgE examination, described test strips is coated with the perfumery antigen of colloid gold label.The present invention utilizes colloidal gold-labeled method, use colloid gold label specificity perfumery anaphylactogen first, then the anaphylactogen after mark is evenly sprayed line in cellulose acetate membrane or nitrocellulose filter, be prepared into test strips product and carry out Allergic skin test, easy and simple to handle, result is accurate, with low cost, can realize multinomially freely detecting.
Description
Technical field
The present invention relates to colloidal gold-labeled method field, specifically, relate to a kind of test strips for specificity perfumery anaphylactogen IgE examination and preparation method thereof.
Background technology
Anaphylactia is modal a kind of disease in contemporary society, it is caused by the anaphylactogen extensively existed, the crowd of China about 5 ~ 10%, US and European about 5 ~ 25% was invaded and harassed by anaphylaxis, wherein child and teenager particularly evident, endanger more serious.Allergic reaction (allergy) is immune body when again contacting identical allergen, and react the excessively violent and physiological dysfunction that causes and tissue damage pathologic immune reaction.Relate to clinical departments, as internal medicine comprises bronchial astehma, anaphylactic shock, serum sickness, connective tissue disease (CTD), glomerulonephritis, antimigraine etc., surgery comprises naltrindole, ear-nose-throat department has allergic rhinitis, exudative otitis media, meniere's disease etc., gynemetrics comprises erythroblastosis fetalis, ophthalmology comprises allergic conjunctivitis, sympathetic ophthalmia, the department of stomatology comprises RAU, dept. of dermatology's disease about more than half is that allergic reaction is sick, also has transfusion reaction, drug allergy, anaphylactic shock etc. in addition.
The investigation statistics data display that in April, 2011, State Statistics Bureau promulgated, National urban population about 5.7 hundred million, wherein have 1.5 hundred million city anaphylactogens morbidity populations, the crowd being throughout the year in anaphylactogen state reaches 5,122 ten thousand people.Estimate accordingly, the Chinese population city allergic disease incidence of disease is 27%, adds non-metropolitan population, and actual Chinese allergic disease number of the infected is about 3.6 hundred million.But nearly ten years, the diagnosis and treatment rate of China anaphylactogen patient is less than 1%, and the anaphylactogen patient of nearly 99% can not get Diagnosis and Treat timely.
According to incompletely statistics, the whole nation 15000 hospitals above county level in introduce UniCAP less than 150, introduction rate only accounts for 1%.This ratio, compared with the introduction rate of other biochemistry detection equipment (about 40 ~ 50%), is enough to illustrate that the in-vitro diagnosis field of anaphylactogen also exists great development space.Meanwhile, Extrinsic allergen checkout equipment and the main dependence on import of reagent, these raw materials all pick up from American-European import anaphylactogen reagent, with the region difference of China patient and ethnic group difference also still to be tested.Based on above-mentioned situation, develop a kind of Allergic skin test system meeting localization requirement, the research and development comprising the Allergic skin test instrument of China's autonomous innovation and reagent are imperative.
The method of Allergic skin test is mainly divided into in-vivo diagnostic and in-vitro diagnosis.In-vivo diagnostic comprises skin diagnosis (qualitative examination) and provocative diagnosis.Common skin diagnosis comprises intracutaneous experiment, pricking method experiment, scratch experiment, patch experiment etc.Provocative diagnosis comprises conjunctiva experiment, nose experiment, bronchus experiment, food experiment, medicine excitation experiment, physical property excitation experiment etc.Because the influence factor of in-vivo diagnostic is complicated, accuracy is low, and result can only be carried out qualitative, and inspection itself brings misery to patient, and to severe allergy, patient even exists the factors such as life danger, limits further developing of in-vivo diagnostic.
The principle of in-vitro diagnosis is based on IgE antibody diagnosis, and diagnostic techniques comprises Diagnosis of Sghistosomiasis notation, radiation allergen absorption diagnosis (RAST), fluorescence enzyme linked immunosorbent assay (FEIA), euzymelinked immunosorbent assay (ELISA) (ELISA) etc.
At present, the method of domestic conventional clinical detection anaphylactogen is based on the In vivo assay Cells of skin puncture test (SPT), namely with the direct pricking method skin of the irritated stoste of dilution, observe check point and whether occur wheal or flare reaction, carry out feminine gender or positive judgement.The advantages such as although SPT has easy, cost is low, patient's visible result.But its result is by many factors, and accuracy is low, inspection itself brings misery to patient especially pediatric patient, and to severe allergy, patient is even in peril of one's life.Domestic in-vitro diagnosis field is in a backward condition, and substantially concentrates on manual operations and sxemiquantitative semi-automated analysis state.There is loaded down with trivial details, the sensitivity of operation and precision poor, the shortcoming that the test duration is grown.
Compared with in vivo studies, only need a small amount of serum can screen and determine hundred kinds of anaphylactogens, have effectiveness parameters reliable, not by drug influence, nonsystemic reaction danger waits remarkable advantage.What Application comparison was outstanding is PHARDIAUNICAP system and SIEMENS diagnostic system.PHARDIAUNICAP system from the seventies come out since, always by the goldstandard as allergen diagnosis.The eighties enters China, is in monopoly position always.And SIEMENS diagnostic system is the representative of anaphylactogen Automation New Technology, is allergen diagnosis system emerging in recent years, not yet enters Chinese market.
In developed country, full-automatic Allergic skin test current is clinically based on euzymelinked immunosorbent assay (ELISA).Conventional two kinds of methods: enzyme linked immunological fluorometry and biotin-avidin system-euzymelinked immunosorbent assay (ELISA).
The classical system of enzyme linked immunological fluorometry is the ImmunoCAP detection system of Pharmacia (Pharmacia) company, and its adopts cellulose solid phase carrier, this solid phase carrier after bromination oxygen activation with anaphylactogen covalent bond.Anaphylactogen is combined on solid phase carrier in advance, hatches for 37 DEG C after adding blood sample, as there being the specific IgE for this anaphylactogen in patients serum, namely forms this anti-allergen antibodies compound anti-.Add the ELIAS secondary antibody of enzyme labeling after wash-out, form the bond of solid phase carrier-anaphylactogen-specific IgE-ELIAS secondary antibody.Again add substrate after wash-out, produce enzyme catalysis fluorescent product.Measure fluorescent value.Specific IgE content is converted into according to the size of fluorescence absorbance.
Biotin-avidin system-euzymelinked immunosorbent assay (ELISA) adopts the ALLERG-O-LIQ Analytical system of Fooke company, and ELISA Plate wraps quilt by antihuman IgE antibody, can be used to detect total IgE and specific IgE.Hatch after adding blood sample and wash, ELISA Plate is in conjunction with all IgE, washing can avoid other immune globulins to disturb (as specific antigen), add biotin labeled anaphylactogen again, then add the Streptavidin bond and chromogenic substrate that combine enzyme, detect the IgE content for specific allergen by the change of absorbance after enzyme-to-substrate reaction.
Summary of the invention
The object of this invention is to provide a kind of test strips for specificity perfumery anaphylactogen IgE examination.
Another object of the present invention is to provide the preparation method of described test strips.
In order to realize the object of the invention, a kind of test strips for specificity perfumery anaphylactogen IgE examination of the present invention, described test strips is coated with the perfumery antigen of colloid gold label.
Particularly, test strips of the present invention is nitrocellulose filter or the cellulose acetate membrane of the perfumery antigen being coated with colloid gold label.
Wherein, the pH value of described test strips is 8.5-10, and the mol ratio between colloid gold particle and perfumery antigen is 10-20:1.Described perfumery includes but not limited to Chinese prickly ash, garlic, ginger, green onion, pepper, capsicum, fennel seeds, Chinese cassia tree, cloves, nutmeg, mustard, peppermint, cassia bark, Gui Ye, Chinese anise, the grey seed in mountain, lemongrass, sweet osmanthus, little Hua jasmine, white orchid, tree orchid, santal, lemon grass (Cymbopogon citratus), Spanish jasmin, lavender, rose, oranges and tangerines, spiceleaf, cumin etc.
Described perfumery antigen is green onion antigen.The preparation method of described green onion antigen is: get fresh green onion 50g, add water 200mL, after freezing, pulverizes with comminutor, then centrifugal in 3000r/min, after precipitation is dried, add the analysis of 200mL toluene wherein and purely carry out ungrease treatment, repeat degreasing more than 5 times, carry out centrifugal after each degreasing terminates, material after centrifugal is placed in fuming cupboard, by the volatilization of the toluene of remnants completely, obtains green onion antigen.
The present invention also provides the preparation method of described test strips, comprises the following steps:
1) preparation of perfumery antigenic solution: be dissolved in the NaCl solution of 0.9%pH7.0 by perfumery antigen to be marked, makes its final concentration be 50-500 μ g/ml, obtains perfumery antigenic solution;
2) preparation of colloidal gold solution: use 0.1MK
2cO
3solution and 0.1MHCl adjust 0.01%HAuCl
4the pH value of colloidal gold solution is to 8.5-10, and make the particle diameter of collaurum reach 40-60nm, concentration reaches 0.5-2%, obtains colloidal gold solution;
3) combination of collaurum and perfumery antigen: use 0.1MK
2cO
3solution adjusts the pH value of the antigenic solution of step 1) to 8.5-10, add step 2 wherein while stirring) colloidal gold solution, the volume ratio of antigenic solution and colloidal gold solution is 1-10:100, add stabilizing agent to prevent perfumery antigen and colloid gold particle polymeric precipitation simultaneously, obtain collaurum-perfumery antigen conjugates; Described stabilizing agent is the polyglycol of BSA (bovine serum albumin(BSA)) and molecular weight 20KD, and the two final concentration is respectively 1% and 0.1%;
4) purifying of the perfumery antigen of colloid gold label: by step 3) in preparation collaurum-perfumery antigen conjugates through the centrifugal 20min of 1500r/min; Collecting precipitation is dissolved in stabilizing agent, makes its concentration reach 5-30%; Then add on SephacrylS-400 chromatographic column and carry out purifying, by the perfumery antigenic solution filtration sterilization of the colloid gold label of purifying, 4 DEG C of preservations; Described stabilizing agent is the polyglycol solution of 1%BSA and 0.1% molecular weight 20KD;
5) the bag quilt of test strips: by step 4) in preparation colloid gold label perfumery antigenic solution spray line in test strips, namely obtain the test strips finished product for specificity perfumery anaphylactogen IgE examination after drying.
Aforesaid preparation method, step 4) in application of sample amount be 1/10 of SephacrylS-400 chromatographic column volume, using stabilizing agent as eluent, flow velocity is 5-10ml/h; Described stabilizing agent is the polyglycol solution of 1%BSA and 0.1% molecular weight 20KD.
During use, test strips of the present invention is immersed in human serum, IgE antibody in serum is combined with specific allergen, produce purple band.Classification is carried out according to bar colored depth contrast ratio colour atla,
The present invention utilizes colloidal gold-labeled method, use colloid gold label specificity perfumery anaphylactogen antigen first, then the anaphylactogen after mark is evenly sprayed line in cellulose acetate membrane or nitrocellulose filter, be prepared into test strips product and carry out Allergic skin test, easy and simple to handle, result is accurate, with low cost, can realize multinomially freely detecting.
Embodiment
Following examples for illustration of the present invention, but are not used for limiting the scope of the invention.If do not specialize, the conventional means that technological means used in embodiment is well known to those skilled in the art, is raw materials usedly commercial goods.
Embodiment is used for test strips of specificity perfumery anaphylactogen IgE examination and preparation method thereof
Preparation for the test strips of specificity green onion anaphylactogen IgE examination comprises the preparation of antigenic solution to be marked, waits to mark the bag quilt of the preparation of colloidal gold solution, colloid gold label green onion antigen, the purifying of collaurum green onion antigen, the particle diameter qualification of collaurum protein body and test strips.Concrete steps are as follows:
1, the preparation of antigenic solution to be marked
The preparation method of green onion antigen is: get fresh green onion 50g, add water 200mL, after freezing, pulverizes with comminutor, then centrifugal in 3000r/min, after precipitation is dried, add the analysis of 200mL toluene wherein and purely carry out ungrease treatment, repeat degreasing more than 5 times, carry out centrifugal after each degreasing terminates, material after centrifugal is placed in fuming cupboard, by the volatilization of the toluene of remnants completely, obtains green onion antigen.
Green onion antigen to be marked is dissolved in the NaCl solution of 0.9%pH7.0, makes its final concentration be 50-500 μ g/ml, obtain green onion antigenic solution.
2, the preparation of marking colloidal gold solution is waited
Use 0.1MK
2cO
3solution or 0.1MHCl adjust the pH value to 9.0 of colloidal gold solution, and make the particle diameter of collaurum reach 50nm, concentration reaches 1%.
3, colloid gold label green onion antigen: collaurum and antigenic solution are used 0.1MK respectively
2cO
3solution adjusts pH to 9.0, and electromagnetic agitation antigenic solution, adds colloidal gold solution, the volume ratio of antigenic solution and colloidal gold solution is 1-10:100, continue to stir 10min, add the polyglycol of stabilizing agent BSA and molecular weight 20KD, obtain the polyglycol solution of 1%BSA and 0.1% molecular weight 20KD.The consumption of this process need adjustment antigen is that grape wine is red for the best with the solution after colloid gold label antigen completes.
4, the purifying of the green onion antigen of colloid gold label: by the collaurum-green onion antigen conjugates of preparation in step 3 through the centrifugal 20min of 1500r/min; Collecting precipitation is dissolved in stabilizing agent (described stabilizing agent is the polyglycol solution of 1%BSA and 0.1% molecular weight 20KD), makes its concentration reach 5-30%; Then add on SephacrylS-400 chromatographic column and carry out purifying, by the green onion antigenic solution filtration sterilization of the colloid gold label of purifying, 4 DEG C of preservations.
In purge process, application of sample amount is 1/10 of SephacrylS-400 chromatographic column volume, and using stabilizing agent (described stabilizing agent is the polyglycol solution of 1%BSA and 0.1% molecular weight 20KD), as eluent, flow velocity is 5-10ml/h.
5, the particle diameter qualification of collaurum protein body
The measurement of colloid gold particle mean diameter: observing colloid gold grain under transmission electron microscope, the mean diameter calculating 100 gold grains should within the scope of 40 ~ 60nm.
6, the bag quilt of test strips
By negative control solution (PBS solution containing 40-70% bovine serum albumin(BSA)), the antigenic solution of step 4 purifying evenly sprays line.
The spray line of negative control and antigenic solution is carried out on immune chromatography test paper nitrocellulose filter surface.Quantitative work is carried out with pneumatic sprayhead.With the three-dimensional platform reciprocal spray of interval back and forth line.Finally that the nitrocellulose filter sprayed is dry and cut slivering.
7, result judges
Carry out classification according to bar colored depth contrast ratio colour atla, stage division is in table 1:
Table 1 grade scale
| IgE concentration in serum | Classification | Specific IgE content |
| ＜0.35IU/mL | 0 | Nothing |
| 0.35-0.75IU/mL | 1 | Low |
| 0.75-3.5IU/mL | 2 | Increase |
| 3.5-17.5IU/mL | 3 | Remarkable increase |
| 17.5-50IU/mL | 4 | Remarkable increase |
| 50-100IU/mL | 5 | Higher |
| ＞100IU/mL | 6 | High |
In visual colorimetry, the band on colorimetric card is for directly to carry out the red spray line of Grape Skin on immune chromatography test paper nitrocellulose filter surface.The concentration difference red according to spray line Grape Skin forms gradient (table 2):
Table 2 different I gE concentration corresponds to the concentration that on colorimetric card, Grape Skin is red
| IgE concentration in serum | The red concentration of Grape Skin |
| ＜0.35IU/mL | Nothing |
| 0.35-0.75IU/mL | 0.25g/L |
| 0.75-3.5IU/mL | 0.5g/L |
| 3.5-17.5IU/mL | 2g/L |
| 17.5-50IU/mL | 5g/L |
| 50-100IU/mL | 9g/L |
| ＞100IU/mL | 12g/L |
Test strips for specificity perfumery anaphylactogen IgE examination provided by the invention is suitable for industrialization large-scale production, reduces production cost, greatly reduces the price that anaphylactogen individual event detects.In addition, to the anaphylactogen raw material with China domestic feature, realize localization, be more suitable for the diagnosis of Chinese population anaphylactogen, improve the accuracy of diagnosis.
Although above the present invention is described in detail with a general description of the specific embodiments, on basis of the present invention, can make some modifications or improvements it, this will be apparent to those skilled in the art.Therefore, these modifications or improvements without departing from theon the basis of the spirit of the present invention, all belong to the scope of protection of present invention.
Claims (3)
1. for a test strips for specificity green onion anaphylactogen IgE examination, it is characterized in that, described test strips is nitrocellulose filter or the cellulose acetate membrane of the green onion antigen being coated with colloid gold label;
The pH value of described test strips is 8.5-10, and the mol ratio between colloid gold particle and green onion antigen is 10-20:1;
The preparation method of described green onion antigen is: get fresh green onion 50g, add water 200mL, after freezing, pulverizes with comminutor, then centrifugal in 3000r/min, after precipitation is dried, add the analysis of 200mL toluene wherein and purely carry out ungrease treatment, repeat degreasing more than 5 times, carry out centrifugal after each degreasing terminates, material after centrifugal is placed in fuming cupboard, by the volatilization of the toluene of remnants completely, obtains green onion antigen.
2. the preparation method of test strips described in claim 1, is characterized in that, comprises the following steps:
1) preparation of green onion antigenic solution: be dissolved in the NaCl solution of 0.9%pH7.0 by green onion antigen to be marked, makes its final concentration be 50-500 μ g/ml, obtains green onion antigenic solution;
2) preparation of colloidal gold solution: use 0.1MK
2cO
3solution and 0.1MHCl adjust 0.01%HAuCl
4the pH value of colloidal gold solution is to 8.5-10, and make the particle diameter of collaurum reach 40-60nm, concentration reaches 0.5-2%, obtains colloidal gold solution;
3) combination of collaurum and green onion antigen: use 0.1MK
2cO
3solution adjusts the pH value of the antigenic solution of step 1) to 8.5-10, add step 2 wherein while stirring) colloidal gold solution, the volume ratio of antigenic solution and colloidal gold solution is 1-10:100, add stabilizing agent to prevent green onion antigen and colloid gold particle polymeric precipitation simultaneously, obtain collaurum-green onion antigen conjugates; Described stabilizing agent is the polyglycol of 1%BSA and 0.1% molecular weight 20KD;
4) purifying of the green onion antigen of colloid gold label: by step 3) in preparation collaurum-green onion antigen conjugates through the centrifugal 20min of 1500r/min; Collecting precipitation is dissolved in stabilizing agent, makes its concentration reach 5-30%; Then add on SephacrylS-400 chromatographic column and carry out purifying, by the green onion antigenic solution filtration sterilization of the colloid gold label of purifying, 4 DEG C of preservations; Described stabilizing agent is the polyglycol solution of 1%BSA and 0.1% molecular weight 20KD;
5) the bag quilt of test strips: by step 4) in preparation colloid gold label green onion antigenic solution spray line in test strips, namely obtain the test strips finished product for specificity green onion anaphylactogen IgE examination after drying.
3. method according to claim 2, is characterized in that, step 4) in application of sample amount be 1/10 of SephacrylS-400 chromatographic column volume, using stabilizing agent as eluent, flow velocity is 5-10ml/h; Described stabilizing agent is the polyglycol solution of 1%BSA and 0.1% molecular weight 20KD.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410232549.3A CN103995106B (en) | 2014-05-28 | 2014-05-28 | For the test strips and preparation method thereof of specificity perfumery anaphylactogen IgE examination |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410232549.3A CN103995106B (en) | 2014-05-28 | 2014-05-28 | For the test strips and preparation method thereof of specificity perfumery anaphylactogen IgE examination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103995106A CN103995106A (en) | 2014-08-20 |
| CN103995106B true CN103995106B (en) | 2016-01-13 |
Family
ID=51309327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410232549.3A Active CN103995106B (en) | 2014-05-28 | 2014-05-28 | For the test strips and preparation method thereof of specificity perfumery anaphylactogen IgE examination |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103995106B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109580953B (en) * | 2018-11-16 | 2021-11-05 | 山西省食品药品检验所(山西省药品包装材料监测中心) | Detection device for spearmint colloidal gold doped in mint and mint decoction pieces, preparation method and application |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002056017A1 (en) * | 2000-10-13 | 2002-07-18 | Dexall Biomedical Labs, Inc. | Lateral flow assay for detection of antibodies in human serum |
| CN101059513A (en) * | 2007-05-31 | 2007-10-24 | 杭州迪恩科技有限公司 | Method and apparatus for detecting drug residue of food |
| CN101266246A (en) * | 2008-04-30 | 2008-09-17 | 天津中新科炬生物制药有限公司 | HIV antibody and antigen combined rapid detection reagent kit |
| CN101387643A (en) * | 2008-10-20 | 2009-03-18 | 杭州浙大生物基因工程有限公司 | Multichannel allergen rapid detection kit and method for making same |
| CN102636650A (en) * | 2012-03-23 | 2012-08-15 | 沃克(天津)生物科技有限公司 | Milk allergen test plate and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7629127B2 (en) * | 2005-01-21 | 2009-12-08 | Dexall Biomedical Labs, Inc. | Method for the visual detection of specific antibodies by the use of lateral flow assays |
-
2014
- 2014-05-28 CN CN201410232549.3A patent/CN103995106B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002056017A1 (en) * | 2000-10-13 | 2002-07-18 | Dexall Biomedical Labs, Inc. | Lateral flow assay for detection of antibodies in human serum |
| US6528325B1 (en) * | 2000-10-13 | 2003-03-04 | Dexall Biomedical Labs, Inc. | Method for the visual detection of specific antibodies in human serum by the use of lateral flow assays |
| CN101059513A (en) * | 2007-05-31 | 2007-10-24 | 杭州迪恩科技有限公司 | Method and apparatus for detecting drug residue of food |
| CN101266246A (en) * | 2008-04-30 | 2008-09-17 | 天津中新科炬生物制药有限公司 | HIV antibody and antigen combined rapid detection reagent kit |
| CN101387643A (en) * | 2008-10-20 | 2009-03-18 | 杭州浙大生物基因工程有限公司 | Multichannel allergen rapid detection kit and method for making same |
| CN102636650A (en) * | 2012-03-23 | 2012-08-15 | 沃克(天津)生物科技有限公司 | Milk allergen test plate and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103995106A (en) | 2014-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109187981A (en) | A kind of quantum dot immune chromatograph test strip of quick detection beta-amyloid protein and application | |
| CN103995112B (en) | For the test strips and preparation method thereof of specificity animal wool dandruff allergens IgE examination | |
| CN108918866A (en) | A kind of marker of inflammation POCT combined detection kit suit | |
| CN105759057A (en) | Dry-type immunofluorescence kit for detecting Alzheimer syndrome MS4A6A and preparation method thereof | |
| CN103983789B (en) | For the test strips and preparation method thereof of specificity dirt mite class anaphylactogen IgE examination | |
| JP4105768B2 (en) | Protein extraction method | |
| CN103995106B (en) | For the test strips and preparation method thereof of specificity perfumery anaphylactogen IgE examination | |
| CN103995116B (en) | For the test strips and preparation method thereof of specificity cephalosporins anaphylactogen IgE examination | |
| CN103995135B (en) | For the test strips and preparation method thereof of specificity mushroom class anaphylactogen IgE examination | |
| CN114107429A (en) | A screening method for the barrier repair efficacy of a cosmetic raw material in vitro 3D skin model | |
| CN103995115B (en) | For the test strips and preparation method thereof of specificity pest type anaphylactogen IgE examination | |
| CN103995113B (en) | For the test strips and preparation method thereof of specificity tetanus antitoxin anaphylactogen IgE examination | |
| CN103995132B (en) | For the test strips and preparation method thereof of specificity cereal anaphylactogen IgE examination | |
| CN103995133B (en) | For the test strips and preparation method thereof of specificity egg white anaphylactogen IgE examination | |
| CN103995131B (en) | For the test strips and preparation method thereof of specificity weeds class pollen allergens IgE examination | |
| CN103983790B (en) | For the test strips and preparation method thereof of specificity silk class anaphylactogen IgE examination | |
| CN103995111B (en) | For the test strips and preparation method thereof of greengrocery food allergen IgE examination | |
| CN103995118B (en) | For the test strips and preparation method thereof of meat anaphylactogen IgE examination | |
| CN103995114B (en) | For the test strips and preparation method thereof of specificity nut fruits anaphylactogen IgE examination | |
| CN103995134B (en) | For the test strips and preparation method thereof of specificity cotton class anaphylactogen IgE examination | |
| CN103995105B (en) | For the test strips and preparation method thereof of specificity detecting insulin allergen IgE examination | |
| CN103995109B (en) | For the test strips and preparation method thereof of specificity fruits anaphylactogen IgE examination | |
| CN103995117B (en) | For the test strips and preparation method thereof of specificity Mycophyta anaphylactogen IgE examination | |
| CN103983788B (en) | For the test strips and preparation method thereof of specificity milk anaphylactogen IgE examination | |
| CN107490693A (en) | A kind of fluorescence immune chromatography method for quantitatively detecting cardiac muscle troponin I and cardic fatty acid binding protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |